Eiger reports loss for quarter

PALO ALTO, Calif. (AP) - Eiger BioPharmaceuticals Inc. (EIGR) on Friday reported a loss of $16.9 million in its fourth quarter. On a per-share basis, the Palo Alto, California-based company said it had a loss of 69 cents. For the year, the company reported that its loss widened to $70.